Send feedback

COG5 p.Pro478Ser

c.1432C>T · rs1279772707 · VCV1429774

Uncertain significance Single submitter
Classification
Uncertain significance
ClinVar
Review
Single submitter ★☆☆☆
ClinVar · 1 submitter
AlphaMissense
likely pathogenic
0.8121 · ACMG-weighted
gnomAD v4.1
Rare
very rare (popmax 0.00133%, afr)
Missense predictors
2/2 damaging
AlphaMissense, SaProt · REVEL no call
Conditions
1
COG5-congenital disorder of glycosylation

Computational evidence

Protein change
AlphaMissense0.8121likely pathogenic
REVEL0.517indeterminate
SaProtLLR -12.22damaging
⇒ AlphaMissense and SaProt both call this damaging; REVEL makes no call.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 12GERP 2.7, phastCons 1
Regional constrainto/e 1.09unconstrained · MANE · 360 kb · p 0.0042 · regional, not allelic
Overall
CADD27.1PHRED · no single calibrated threshold — expert panels disagree

ClinVar classifies this uncertain; the computational predictors unanimously lean damaging — a triage signal, not a reclassification

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

⚠ Isoform check: AlphaMissense numbered on a different transcript (AM P509S vs ClinVar P478S) — verify the residue.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.00133% African / African-American · 1/75,022 alleles
Filtering AF 0.000247% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.000159%
Overall 0.000558% 9/1,613,988 alleles · very rare exomes 9/1,461,744 · genomes 0/152,244 · joint denominator
Ancestry group Frequency 1 in
Remaining individualsnot grpmax-eligible 0.0016% 62,498
African / African-Americangrpmax 0.00133% 75,022
European (non-Finnish) 0.000593% 168,563

Remaining individuals shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
COG5
Protein
p.Pro478Ser
Coding
c.1432C>T
MANE Select
NM_006348
dbSNP
rs1279772707
Type
single nucleotide variant
Location
chr7:107283614 (GRCh38)
Gene constraint
LOEUF 1.026 · pLI <0.01 (gnomAD)
Structure
AlphaFold pLDDT 84.37
Full COG5 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/cog5-p-pro478ser (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown